Final overall survival data of sintilimab plus pemetrexed and platinum as First-Line treatment for locally advanced or metastatic nonsquamous NSCLC in the Phase 3 ORIENT-11 study

Post time Half hour(s) ago

journal：Lung Cancer

Authors：Li Zhang; Zhehai Wang; Jian Fang; Qitao Yu; Baohui Han; Shundong Cang; Gongyan Chen; Xiaodong Mei; Zhixiong Yang; Victoria Stefaniak; Yong Lin; Shuyan Wang; Wen Zhang; Luyao Sun; Yunpeng Yang

Published date：2022-9-

DOI：10.1016/j.lungcan.2022.07.013

PDF link：https://www.sciencedirect.com/sc ... 169500222005530/pdf

Article link：https://doi.org/10.1016/j.lungcan.2022.07.013

Article Source：Elsevier BV。

Remark：

Post time Half hour(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time Half hour(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] Final overall survival data of sintilimab plus pemetrexed and platinum as First-Line treatment for locally advanced or metastatic nonsquamous NSCLC in the Phase 3 ORIENT-11 study

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors